Clinical Trial Update: Amphotericin-B and Voriconazole for Pulmonary Blastomycosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on amphotericin-B and voriconazole for pulmonary blastomycosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blastomycosis

Drugs mentioned

• Amphotericin B (Amphotericin B)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: University of Manitoba | Conditions: Blastomycosis | Phase 4 | Status: TERMINATED